Clinical Trials
67 trialsPROMESSE
Institut du Cancer de Montpellier - Val d'Aurelle
IMOTEP
Centre Antoine Lacassagne
FCI in Post-operative Low Grade Gliomas
NHS Grampian
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients
NaviFUS Corporation
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
GLAD
Wake Forest University Health Sciences
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
InSightec
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
Washington University School of Medicine
TEMOIN
Institut du Cancer de Montpellier - Val d'Aurelle
Quality of Life and Cognitive Functioning in Patients With Glial Tumors
Institute of Oncology Ljubljana
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
Application of Cognitive Training Based on the Remind Strategy in Glioma Patients With Cognitive Impairment
LanZhou University
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
InSightec
SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
SonoClear AS
DORA
Central Hospital, Nancy, France
RF2019-1236878
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors
M.D. Anderson Cancer Center
Psychological Intervention For Brain Tumor Caregivers
Massachusetts General Hospital
Glioma
The Affiliated Brain Hospital of Nanjing Medical University
Resting-State Functional MRI in Glioma Patients Before and After Surgery
M.D. Anderson Cancer Center
Psychological Intervention for Caregivers of Patients With Malignant Gliomas
Massachusetts General Hospital
18F-FET PET/CT in the Management of Glioma
Buddhist Tzu Chi General Hospital
FearLess
Virginia Commonwealth University
ELASTOGLI
University Hospital, Tours
CARES
Rigshospitalet, Denmark
Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
Medical University of Warsaw
Mindfulness Meditation in Glioma Patients
Duke University
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
Mayo Clinic
Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma
Istituto Clinico Humanitas
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
OHSU Knight Cancer Institute
ERISA
Centre Hospitalier Universitaire de Besancon
Glioma and Exercising
University Hospital, Basel, Switzerland
SonoRCT
Tata Memorial Hospital
Exercise in Patients With Glioblastoma
University Health Network, Toronto
LSCI-NSURG
Insel Gruppe AG, University Hospital Bern
MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas
Ottawa Hospital Research Institute
GlucoCEST MRI in Oncology
University College, London
ERGO2
Johann Wolfgang Goethe University Hospital
Image-Guided Stereotactic Biopsy of High Grade Gliomas
Memorial Sloan Kettering Cancer Center
Early Palliative Care Intervention in Malignant Glioma
Duke University
Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory
Virginia Commonwealth University
Hypofractionated IMRT With Temozolomide for HGG
Istituto Clinico Humanitas
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Jonsson Comprehensive Cancer Center
CERVO1
University Hospital, Angers
GMaPIC
Centre Jean Perrin
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
NaviFUS Corporation
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
University of Washington
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CINDERELLA
University Hospital Heidelberg